Heart Function in HIV-Negative Children Exposed to HIV and HAART
NCT01107834 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60
Last updated 2016-07-20
Summary
HIV-uninfected children born to HIV+ women have low level heart problems at birth which may predispose them to heart failure, arrythmias and heart attack later in life. The impact of these heart problems on future heart health is unclear as it is unknown if heart problems in these children persist, worsen or resolve in pre-pubescence. The objective of this study is to characterize heart function in HIV-negative pre-pubertal children born to HIV+ women and exposed to HIV and HAART in utero and compare them to age and gender matched healthy children born to HIV-negative women. Through this objective we will determine if heart problems in HIV-negative children born to HIV+ women and exposed to HAART in utero persists, worsens, or resolves during pre-pubescence.
Conditions
- HIV Infections
Sponsors & Collaborators
- collaborator INDUSTRY
-
Washington University School of Medicine
lead OTHER
Principal Investigators
-
William T Cade, PhD · Washington University School of Medicine
Eligibility
- Min Age
- 5 Years
- Max Age
- 12 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2010-05-31
- Primary Completion
- 2011-12-31
- Completion
- 2011-12-31
Countries
- United States
Study Locations
More Related Trials
-
A Study of Zidovudine in Infants Exposed to the HIV Before or Soon After Birth
NCT00001007 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Safety and Tolerability of Zidovudine (ZDV) in Premature Infants Born to HIV-Positive Women.
NCT00000855 ·Status: COMPLETED ·Phase: NA
-
Safety and Pharmacokinetics Study of PGT121.414.LS Alone and in Combination With VRC07-523LS in Infants Exposed to HIV-1
NCT06517693 ·Status: RECRUITING ·Phase: PHASE1
-
Immune Function of Infants With HIV
NCT00073229 ·Status: COMPLETED
-
Cardiometabolic Health of Children Exposed to Anti-retroviral Therapy (ART) in Utero
NCT04763668 ·Status: UNKNOWN
-
Pneumococcal Vaccine and Routine Pediatric Immunizations in HIV-Infected Children Receiving Anti-HIV Drugs
NCT00013871 ·Status: COMPLETED ·Phase: NA
-
Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission
NCT02140255 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Therapeutic Drug Monitoring and Viral Resistance Testing in the Treatment of HIV-Infected Children
NCT00032669 ·Status: COMPLETED ·Phase: PHASE1
-
Natural History Study of HIV Acquired in Infancy or Childhood
NCT00924365 ·Status: COMPLETED
-
Pregnancy, Anti-integrase and Lymphocyte Repertoire of the Newborn
NCT04024150 ·Status: COMPLETED
-
ARVs to Prevent Breastmilk HIV:Viral and Immune Responses
NCT00167674 ·Status: COMPLETED ·Phase: PHASE2
-
Stopping and Restarting Anti-HIV Drugs in Children and Adolescents With Low Blood Levels of HIV
NCT00016783 ·Status: COMPLETED
-
Safety and Pharmacokinetics of Raltegravir in HIV-1-Exposed Newborn Infants at Risk of Acquiring HIV-1 Infection
NCT01780831 ·Status: COMPLETED ·Phase: PHASE1
-
A Prospective, Observational Study of HIV-Infected Pregnant Women and Their Infants at Clinical Sites in Latin American and Caribbean Countries
NCT00341302 ·Status: COMPLETED
-
HIV Diagnosis and Treatment at Birth for Newborn With High Risk HIV Exposure
NCT03642704 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Anti-HIV Therapy on Red Blood Cells of HIV-infected Mothers and Their Infants
NCT00342082 ·Status: COMPLETED
-
A Study to Collect Information About HIV-Positive Pregnant Women and Their Babies
NCT00000910 ·Status: COMPLETED
-
Evaluating the Safety and Pharmacokinetics of VRC01, VRC01LS, and VRC07-523LS, Potent Anti-HIV Neutralizing Monoclonal Antibodies, in HIV-1-Exposed Infants
NCT02256631 ·Status: COMPLETED ·Phase: PHASE1
-
Prenatal and Postnatal Studies of Interventions for Prevention of Mother-To-Child Transmission
NCT00028145 ·Status: COMPLETED
-
Anti-HIV Drugs for Treating Infants Who Acquired HIV Infection at Birth
NCT00102960 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Delavirdine Mesylate in Combination With Other Anti-HIV Drugs in HIV-Infected Children and Babies
NCT00002210 ·Status: COMPLETED ·Phase: PHASE2
-
A Prospective Cohort of Children With HIV Infection
NCT00476606 ·Status: COMPLETED
-
A Phase III Study to Evaluate the Safety, Tolerance, and Efficacy of Early Treatment With Zidovudine (AZT) in Asymptomatic Infants With HIV Infection
NCT00000750 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Maternal Anti-HIV Treatment on Infants Born to HIV-Infected Women
NCT00100867 ·Status: COMPLETED
-
Evaluating Strategies to Reduce Mother-to-Child Transmission of HIV Infection in Resource-Limited Countries
NCT01061151 ·Status: COMPLETED ·Phase: PHASE3